Endothelium-derived hyperpolarising factors and associated pathways: a synopsis.
The term endothelium-derived hyperpolarising factor (EDHF) was introduced in 1987 to describe the hypothetical factor responsible for myocyte hyperpolarisations not associated with nitric oxide (EDRF) or prostacyclin. Two broad categories of EDHF response exist. The classical EDHF pathway is blocked by apamin plus TRAM-34 but not by apamin plus iberiotoxin and is associated with endothelial cell hyperpolarisation. This follows an increase in intracellular [Ca(2+)] and the opening of endothelial SK(Ca) and IK(Ca) channels preferentially located in caveolae and in endothelial cell projections through the internal elastic lamina, respectively. In some vessels, endothelial hyperpolarisations are transmitted to myocytes through myoendothelial gap junctions without involving any EDHF. In others, the K(+) that effluxes through SK(Ca) activates myocytic and endothelial Ba(2+)-sensitive K(IR) channels leading to myocyte hyperpolarisation. K(+) effluxing through IK(Ca) activates ouabain-sensitive Na(+)/K(+)-ATPases generating further myocyte hyperpolarisation. For the classical pathway, the hyperpolarising "factor" involved is the K(+) that effluxes through endothelial K(Ca) channels. During vessel contraction, K(+) efflux through activated myocyte BK(Ca) channels generates intravascular K(+) clouds. These compromise activation of Na(+)/K(+)-ATPases and K(IR) channels by endothelium-derived K(+) and increase the importance of gap junctional electrical coupling in myocyte hyperpolarisations. The second category of EDHF pathway does not require endothelial hyperpolarisation. It involves the endothelial release of factors that include NO, HNO, H(2)O(2) and vasoactive peptides as well as prostacyclin and epoxyeicosatrienoic acids. These hyperpolarise myocytes by opening various populations of myocyte potassium channels, but predominantly BK(Ca) and/or K(ATP), which are sensitive to blockade by iberiotoxin or glibenclamide, respectively.
Edwards
Gillian
G
Faculty of Life Sciences, University of Manchester, CTF Building, 46 Grafton St, Manchester, M13 9NT, UK.
Félétou
Michel
M
Weston
Arthur H
AH
D000818:Animals; D001030:Apamin / Q000494:pharmacology; D001685:Biological Factors / Q000502:physiology*; D002248:Carbon Monoxide / Q000502:physiology; D015777:Eicosanoids / Q000502:physiology; D004730:Endothelium, Vascular / Q000502:physiology; D045462:Endothelium-Dependent Relaxing Factors / Q000502:physiology*; D011464:Epoprostenol / Q000502:physiology; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D032342:Muscle Cells / Q000502:physiology; D020098:Natriuretic Peptide, C-Type / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology; D011188:Potassium / Q000502:physiology; D026902:Potassium Channel Blockers / Q000494:pharmacology; D015221:Potassium Channels / Q000502:physiology*; D024681:Potassium Channels, Calcium-Activated / Q000502:physiology; D011720:Pyrazoles; D051640:Small-Conductance Calcium-Activated Potassium Channels / Q000502:physiology; D000254:Sodium-Potassium-Exchanging ATPase / Q000502:physiology
D001685:Biological Factors; D015777:Eicosanoids; D045462:Endothelium-Dependent Relaxing Factors; D026902:Potassium Channel Blockers; D015221:Potassium Channels; D024681:Potassium Channels, Calcium-Activated; D011720:Pyrazoles; D051640:Small-Conductance Calcium-Activated Potassium Channels; C411671:TRAM 34; C067410:endothelium-dependent hyperpolarization factor; D020098:Natriuretic Peptide, C-Type; D001030:Apamin; D009569:Nitric Oxide; D002248:Carbon Monoxide; D006861:Hydrogen Peroxide; D011464:Epoprostenol; D000254:Sodium-Potassium-Exchanging ATPase; D011188:Potassium
Circ Res. 2003 Jul 25;93(2):124-31
12805243
Nature. 1998 Nov 19;396(6708):269-72
9834033
Trends Pharmacol Sci. 1998 Jun;19(6):229-41
9666714
Br J Pharmacol. 1981 Oct;74(2):495-504
6274466
Circ Res. 2000 Feb 18;86(3):341-6
10679487
Stroke. 1997 Nov;28(11):2290-4; discussion 2295
9368578
Nature. 2003 Jul 24;424(6947):434-8
12879072
Br J Pharmacol. 2010 Jun;160(4):836-43
20233221
Circ Res. 2000 Jul 21;87(2):160-6
10904001
Br J Pharmacol. 1988 Mar;93(3):515-24
2453240
Nature. 1999 Sep 30;401(6752):493-7
10519554
J Cardiovasc Pharmacol. 1998 Mar;31(3):377-83
9514182
Br J Pharmacol. 2000 Mar;129(6):1145-54
10725263
Blood Vessels. 1991;28(1-3):52-61
1848126
Br J Pharmacol. 2009 Jun;157(4):537-9
19630833
Am J Respir Cell Mol Biol. 1998 Sep;19(3):485-97
9730877
Br J Pharmacol. 1978 Dec;64(4):493-501
728678
J Physiol. 1995 Apr 15;484 ( Pt 2):469-80
7541469
J Physiol. 1999 Mar 15;515 ( Pt 3):639-51
10066894
Am J Physiol Heart Circ Physiol. 2001 Oct;281(4):H1553-60
11557543
Br J Pharmacol. 2005 Jul;145(6):775-84
15895105
Circulation. 2008 Feb 26;117(8):1065-74
18268148
Pflugers Arch. 2010 May;459(6):915-22
20140449
Br J Pharmacol. 2005 Feb;144(4):477-85
15655533
J Physiol. 1998 Apr 15;508 ( Pt 2):561-73
9508817
J Anat. 2006 Nov;209(5):689-98
17062025
Nature. 1984 Apr 12-18;308(5960):645-7
6424031
J Physiol. 1997 Nov 1;504 ( Pt 3):537-43
9401962
Br J Pharmacol. 2001 Sep;134(1):1-5
11522590
Br J Pharmacol. 2008 Jun;154(3):652-62
18414396
Nat Cell Biol. 2001 Feb;3(2):121-7
11175743
Circ Res. 2009 Apr 24;104(8):987-94
19299646
Mol Pharmacol. 2009 Nov;76(5):1115-22
19720727
Circ Res. 2005 Aug 19;97(4):399-407
16037574
Endothelium. 2003;10(1):5-15
12699072
Br J Pharmacol. 2002 Jul;136(6):918-26
12110616
Can J Physiol Pharmacol. 1998 Jan;76(1):1-15
9564544
Circ Res. 2002 Oct 4;91(7):610-7
12364389
Br J Pharmacol. 2000 Mar;129(6):1103-12
10725258
Circ Res. 1990 Mar;66(3):608-21
2106399
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10763-8
10995472
J Physiol. 1984 Oct;355:43-63
6092628
Hypertension. 2007 Mar;49(3):590-6
17200437
Br J Pharmacol. 1988 Dec;95(4):1165-74
2851359
J Biol Chem. 1999 Apr 16;274(16):10927-35
10196172
Circ Res. 2006 Apr 28;98(8):1072-80
16574908
Am J Physiol. 1996 Jan;270(1 Pt 2):F69-81
8769824
Nature. 1994 Apr 28;368(6474):850-3
7512692
J Physiol. 2003 Nov 15;553(Pt 1):183-9
14555724
J Cardiovasc Pharmacol. 1999 Oct;34(4):567-74
10511133
Biochem Biophys Res Commun. 1991 Apr 15;176(1):378-84
1708249
Eur J Pharmacol. 2004 May 10;492(1):13-9
15145700
Br J Pharmacol. 2003 Jul;139(5):982-8
12839872
J Pharmacol Exp Ther. 1997 Feb;280(2):702-9
9023282
J Physiol. 1996 Apr 15;492 ( Pt 2):419-30
9019539
Cell Calcium. 2008 Aug;44(2):210-9
18221783
J Physiol. 2001 Mar 1;531(Pt 2):359-73
11230509
Am J Physiol. 1988 Aug;255(2 Pt 1):C214-25
3407766
Circ Res. 2000 Apr 28;86(8):897-905
10785513
Pharmacol Res. 2004 Jun;49(6):509-14
15026028
J Physiol. 1979 Aug;293:119-33
501578
Am J Physiol. 1990 Mar;258(3 Pt 2):H836-41
2316697
Endocrinology. 1993 Dec;133(6):3038-41
8243333
Hypertension. 2003 Jun;41(6):1301-7
12743008
J Physiol. 1995 Jul 1;486 ( Pt 1):47-58
7562643
J Hypertens. 2005 Mar;23(3):571-9
15716699
J Clin Invest. 2000 Dec;106(12):1521-30
11120759
Br J Pharmacol. 1999 Nov;128(5):1064-70
10556944
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8151-6
10884437
Br J Pharmacol. 2000 Jan;129(2):315-22
10694238
Br J Pharmacol. 2001 Aug;133(7):1145-53
11487526
Am J Physiol. 1997 Mar;272(3 Pt 2):H1147-56
9087587
J Physiol. 1994 Dec 1;481 ( Pt 2):407-14
7738833
Hypertension. 2009 Mar;53(3):532-8
19188524
Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H2704-12
11087224
Clin Exp Pharmacol Physiol. 2004 Sep;31(9):641-9
15479173
Circ Res. 2005 Oct 28;97(9):853-63
16254217
J Biol Chem. 2000 Apr 21;275(16):11934-42
10766822
Br J Pharmacol. 2009 Nov;158 Suppl 1:S1-254
19883461
J Physiol. 1984 Jun;351:549-72
6431087
J Pharmacol Exp Ther. 2009 Jan;328(1):231-9
18836067
Biochem Biophys Res Commun. 2002 Jan 25;290(3):909-13
11798159
Hypertension. 2007 Apr;49(4):885-92
17309955
Trends Pharmacol Sci. 1988 Aug;9(8):272-4
3074543
Pharmacol Res. 2004 Jun;49(6):535-41
15026031
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2612-8
17872452
Hypertension. 2003 Oct;42(4):562-8
12925561
Cardiovasc Res. 2007 Jun 1;74(3):515-25
17391657
Pflugers Arch. 2010 May;459(6):881-95
20224870
Circulation. 2009 May 5;119(17):2323-32
19380617
Br J Pharmacol. 2008 Jan;153(1):57-65
17906681
Br J Pharmacol. 2002 Mar;135(5):1133-43
11877319
Am J Physiol. 1995 Jul;269(1 Pt 1):C1-10
7543240
Physiol Rev. 2007 Jan;87(1):165-217
17237345
J Biol Chem. 1990 Sep 15;265(26):15564-71
1697593
Am J Physiol Heart Circ Physiol. 2002 Jan;282(1):H335-41
11748079
Hypertension. 1997 Jan;29(1 Pt 2):262-7
9039112
Br J Pharmacol. 2009 Jun;157(4):540-50
19338582
Nature. 1980 Nov 27;288(5789):373-6
6253831
Circ Res. 1996 Oct;79(4):631-46
8831487
J Cardiovasc Pharmacol. 1999 May;33(5):779-84
10226866
J Ultrastruct Res. 1967 Apr;18(1):181-223
5337871
J Physiol. 1995 Dec 15;489 ( Pt 3):723-34
8788937
Circ Res. 2005 Dec 9;97(12):1270-9
16269659
Br J Pharmacol. 2007 Jun;151(3):332-40
17450174
Physiology (Bethesda). 2009 Feb;24:26-35
19196649
Am J Physiol Heart Circ Physiol. 2001 Jun;280(6):H2424-9
11356594
Circulation. 2003 Feb 11;107(5):769-76
12578883
Br J Pharmacol. 1996 Apr;117(7):1600-6
8730760
Br J Pharmacol. 2002 Dec;137(8):1346-54
12466245
J Biol Chem. 1999 May 21;274(21):14838-49
10329683
Br J Pharmacol. 2000 Nov;131(5):965-73
11053218
Br J Pharmacol. 2008 Jan;153(1):4-5
17965742
Am J Physiol Lung Cell Mol Physiol. 2009 Feb;296(2):L248-56
19036874
Nature. 1998 Oct 1;395(6701):503-7
9774106
Circ Res. 1997 Aug;81(2):258-67
9242187
Nature. 1990 Jul 5;346(6279):69-71
2366864
Am J Physiol. 1995 Apr;268(4 Pt 1):C799-822
7733230
Trends Pharmacol Sci. 2008 Dec;29(12):601-8
18835046
Br J Pharmacol. 2002 Jan;135(1):155-69
11786491
Circ Res. 2005 Aug 19;97(4):391-8
16037572
FASEB J. 2002 Nov;16(13):1792-8
12409322
Microcirculation. 2009 May;16(4):307-22
19330678
Circ Res. 2008 May 23;102(10):1247-55
18403729
Physiol Rev. 2001 Oct;81(4):1415-59
11581493
Br J Pharmacol. 2004 Mar;141(6):881-903
15028638
Pflugers Arch. 2008 Oct;457(1):137-47
18437413
Am J Physiol Cell Physiol. 2008 Mar;294(3):C856-66
18160488
Stroke. 2006 May;37(5):1277-82
16556879
Am J Physiol. 1998 Nov;275(5):F633-50
9815123
Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10860-4
1961756
Nature. 1986 Oct 23-29;323(6090):718-20
2430185
Br J Pharmacol. 1989 Feb;96(2):418-24
2924084
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1426-31
12552127
Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1545-54
12234808
Prog Drug Res. 1998;50:107-33
9670777
Eur J Pharmacol. 2005 Apr 25;513(3):219-24
15862803
Br J Pharmacol. 2000 Feb;129(3):605-11
10711361
Br J Pharmacol. 1999 Dec;128(8):1788-94
10588935
Br J Pharmacol. 1996 Nov;119(5):959-64
8922746
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9627-32
18621682